Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Ebastine may promote hair regrowth by increasing cell growth through the ERK pathway.

Early regulatory T cells are crucial for normal skin pigmentation.

Certain gene variations in the Vitamin D Receptor are linked to higher risk of female hair loss.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Lack of Evi in skin causes psoriasis-like symptoms in mice.

Including androgens in hormone therapy may lower breast cancer risk.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

IL-15 helps maintain hair growth and protects the immune status of hair follicles.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

RIPK1 inhibitors may help prevent alopecia areata by reducing immune cell activity.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

The assay effectively identifies compounds that affect immune cell activation.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The fragrance cyclohexyl salicylate helps promote hair growth and increase hair stem cell numbers.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Live vaccines can be safely given to infants with a FOXN1 variant if their immune function improves over time.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.